BP1.3656

DRUG3 trials

Sponsors

Centre for Addiction and Mental Health, Bioprojet, Bioprojet Pharma

Conditions

Alcohol Use DisorderFatiguealcohol use disorder alcoholism

Phase 2

A multisite randomized clinical trial evaluating BP1.3656 vs placebo for alcohol use disorder treatment.

Bioprojet Pharmaalcohol use disorder alcoholism

Target: 15Updated: 2024-02-28

Role of BP1.3656 on Alcohol Responses

CompletedNCT04727086

Centre for Addiction and Mental HealthAlcohol Use Disorder

Start: 2021-02-01End: 2022-08-31Updated: 2023-04-05

Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke

TerminatedNCT05240560

BioprojetFatigue

Start: 2023-01-20End: 2024-02-08Updated: 2024-08-09